Analgesia in patients undergoing breast cancer surgery
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1. Patients voluntarily participate in clinical research and sign informed consent; 2. ASA I~II grade; 3. Aged 18 to 75 years; 4. Body mass index 18~25kg/m2; 5. The estimated operation time is 2~4h.
Exclusion criteria
Exclusion criteria: 1. Complicated with severe cardiovascular disease; 2. History of severe liver and kidney disease; 3. Combined with severe endocrine system diseases; 4. Complicated with severe blood system diseases or abnormal coagulation function and long-term use of antiplatelet and antithrombotic drugs; 5. Have a history of allergy to the drugs required for this study; 6. Pregnant women; 7. Combined with central nervous system or peripheral nervous system diseases; 8. Complicated with mental illness or cognitive dysfunction and unable to cooperate in completing the evaluation of various indicators; 9. There are contraindications to erector spinae plane block; 10. There is a history of chronic pain and long-term use of analgesic or sedative drugs.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Interleukin-6; | — |
Secondary
| Measure | Time frame |
|---|---|
| Visual analogue score;Sufentanil dosage;Propofol dosage;Remifentanil dosage;Rocuronium dosage;Postoperative patient-controlled intravenous analgesia pump dosage;Nausea and vomiting;First exhaust time after operation;The first time to get out of bed after operation;Postoperative hospital stay; | — |
Countries
China
Contacts
Xing'an League People's Hospital